MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
The Lancet Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

832 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
832 works in the cohort · of 4,299,418page 6 of 17

Labels cover 9 of 832 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 832 of 832 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Marina Chiara Garassino, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Giovanna Speranza, Manuel Dómine +13 more
2020· article· en· The Lancet Oncology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
213
citations
affno abstractunlabeled
Sebaceous carcinoma: evidence-based clinical practice guidelines
Joshua L. Owen, Nour Kibbi, Brandon Worley, Ryan C. Kelm, Jordan V. Wang, Christopher A. Barker +51 more
2019· review· en· The Lancet Oncology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+insufficient_payloadconsensus · none
205
citations
afffundno abstractunlabeled
Proteins with whey-acidic-protein motifs and cancer
D. Bouchard, Dany Morisset, Yves Bourbonnais, Guy M. Tremblay
2006· review· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
200
citations
affno abstractgemma · no categorygpt · no categorymodels split
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Renée L. Mulder, Anna Font‐Gonzalez, Daniel M. Green, Erik A. H. Loeffen, Melissa M. Hudson, Jacqueline J. Loonen +48 more
2021· review· en· The Lancet Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
200
citations
affno abstractunlabeled
Management of Wilms' tumour: current practice and future goals
John A. Kalapurakal, Jeffrey S. Dome, Elizabeth J. Perlman, Marcio H. Malogolowkin, Gerald M. Haase, Paul E. Grundy +1 more
2003· review· en· The Lancet Oncology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
197
citations
← previousnext →

How this was built: Screen · Findings · About